Panacea has new CEO to add to new name

Sensei Biotherapeutics, a privately-held company known as Panacea Pharmaceuticals until earlier this year, has announced the appointment of John Celebi (pictured) as chief executive, as the company seeks to push forward with its lead cancer vaccine.

Most recently chief operating officer of X4 Pharmaceuticals, Mr Celebi was also chief business officer with Igenica Biotherapeutics and vice president of business development with US biotech firm ArQule (Nasdaq: ARQL), roles in which he has developed alliances with some of the industry's most prominent firms including Roche (ROG: SIX) and Japanese pharma major Daiichi-Sankyo (TYO: 4568).

"John’s oncology background and accomplished track record in biotech will serve Sensei exceptionally well as we move forward with our innovative immuno-oncology platform and advance new medicines for patients," said Sensei co-founder, chief scientific officer and chairman Hossein Ghanbari.